Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function

膳食类胡萝卜素的裂解产物:发生情况

基本信息

  • 批准号:
    8403982
  • 负责人:
  • 金额:
    $ 35.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-07-01 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Consumption of dietary carotenoids is associated with a decreased risk of cardiovascular disease and cancer. Humans obtain carotenoids in the diet by ingesting fruits and vegetables. Historically, it was thought that the most important role of some carotenoids was their metabolic conversion via cleavage at the central double bond to the essential micronutrient, vitamin A (retinol). There is intense recent interest in the "eccentric cleavage" of dietary carotenoids to apocarotenals and their possible oxidation to apocarotenoic acids. These metabolites of carotenoids may play important roles in the non-vitamin A activities of carotenoids. There are no quantitative analyses of the levels of these compounds in human foods and tissues. Demonstrations of the extent of metabolism of intact carotenoids to these compounds and studies of their mechanisms of action are lacking. We will address these gaps in knowledge. (1) We determine the substrate specificity and characterize the products of the two known human carotenoid-metabolizing enzymes (BCO1 & BCO2). These studies will also establish the relationship of cellular retinol-binding proteins and carotenoid cleavage enzymes in the metabolic function of these enzymes. (2) We will demonstrate the relevance of apocarotenoids in humans using analytical chemistry to characterize the presence and quantify the amounts of apo-carotenals and apocarotenoic acids in human plasma and tissues and in foods. This will be accomplished by quantitation of the immediate post- prandial plasma concentrations of parent carotenoids and metabolites after subjects consume a single serving of tomato juice containing nutritionally relevant amounts of beta-carotene or lycopene as well as by quantitation of steady state concentrations in plasma after 4 weeks of daily consumption. (3) We will use the LNCaP cell, a human prostate cancer cell that demonstrates lycopene-dependent growth inhibition and expresses BCO2 to look for apolycopenals and apolycopenoic acids in lycopene-treated cells to address whether and to what extent lycopene is metabolized in these cells. We will use the human monocyte/macrophage cell, U937, which is growth inhibited and induced to differentiate with carotenoid treatment, to look for metabolism of the parent carotenoids. (4) We will probe the biological (nutritional) function of carotenoid metabolites in multiple ways: (a) we will use cell lines that we have shown have characteristic functional responses to treatment with dietary carotenoids and ask whether these responses are obtained by direct treatment with the cleavage products and (b) we will ask whether these cleavage products and metabolites directly activate or antagonize ligand-dependent transcription factors. (c) We will feed the BCO1 knockout mouse both beta-carotene and lycopene to assess the extent of the metabolism of these carotenoids by BCO2 and the metabolic effects of carotenoid metabolites in the whole animal. The results will enhance our understanding of the molecular basis for the health-promoting effects of diets rich in fruits and vegetables.
描述(由申请人提供):饮食中类胡萝卜素的摄入与心血管疾病和癌症风险的降低有关。人类通过摄入水果和蔬菜来获得饮食中的类胡萝卜素。历史上,人们认为一些类胡萝卜素最重要的作用是通过中央双键裂解必需的微量营养素维生素A(视黄醇)来进行代谢转化。最近,人们对膳食类胡萝卜素“偏心裂解”成脱脂胡萝卜素以及它们可能氧化成脱脂胡萝卜素酸产生了浓厚的兴趣。这些类胡萝卜素代谢产物可能在类胡萝卜素的非维生素A活性中发挥重要作用。目前还没有对人类食物和组织中这些化合物水平的定量分析。关于完整类胡萝卜素对这些化合物的代谢程度及其作用机制的研究还缺乏证据。我们将解决这些知识上的差距。(1)我们确定了两种已知的人类类胡萝卜素代谢酶(BCO1和BCO2)的底物特异性,并对其产物进行了表征。这些研究还将确定细胞视黄醇结合蛋白和类胡萝卜素裂解酶在这些酶的代谢功能中的关系。(2)我们将使用分析化学来证明类胡萝卜素在人类中的相关性,以确定人类血浆、组织和食物中类胡萝卜素和非胡萝卜素的存在和数量。这将通过在受试者食用一份含有营养相关数量的β-胡萝卜素或番茄红素的番茄汁后立即定量测定父母类胡萝卜素和代谢物的血浆浓度,以及通过量化每日食用4周后血浆中的稳态浓度来实现。(3)我们将使用LNCaP细胞,这是一种表现出番茄红素依赖的生长抑制并表达BCO2的人前列腺癌细胞,在番茄红素处理的细胞中寻找脱脂蛋白和脱脂蛋白烯酸,以解决番茄红素在这些细胞中是否代谢以及代谢到什么程度。我们将使用生长抑制并诱导分化的人单核/巨噬细胞U937细胞与类胡萝卜素处理,寻找亲本类胡萝卜素的代谢。(4)我们将通过多种方式探索类胡萝卜素代谢物的生物学(营养)功能:(A)我们将使用我们已经显示出对膳食类胡萝卜素处理具有特有功能反应的细胞系,并询问这些反应是否通过与切割产物直接处理而获得;以及(B)我们将询问这些切割产物和代谢物是否直接激活或拮抗配体依赖的转录因子。(C)我们将喂饲BCO1基因敲除小鼠β-胡萝卜素和番茄红素,以评估BCO2对这些类胡萝卜素的代谢程度,以及类胡萝卜素代谢物在整个动物中的代谢影响。这一结果将加深我们对富含水果和蔬菜的饮食促进健康效果的分子基础的理解。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
β-Apo-13-carotenone regulates retinoid X receptor transcriptional activity through tetramerization of the receptor.
β-Apo-13-胡萝卜素通过受体的四聚化调节类维生素A X 受体的转录活性。
  • DOI:
    10.1074/jbc.m114.610501
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sun,Jian;Narayanasamy,Sureshbabu;CurleyJr,RobertW;Harrison,EarlH
  • 通讯作者:
    Harrison,EarlH
Novel cell culture medium for use in oxidation experiments provides insights into mechanisms of endothelial cell-mediated oxidation of LDL.
用于氧化实验的新型细胞培养基提供了对内皮细胞介导的 LDL 氧化机制的见解。
Avocado consumption enhances human postprandial provitamin A absorption and conversion from a novel high-β-carotene tomato sauce and from carrots.
  • DOI:
    10.3945/jn.113.187674
  • 发表时间:
    2014-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kopec RE;Cooperstone JL;Schweiggert RM;Young GS;Harrison EH;Francis DM;Clinton SK;Schwartz SJ
  • 通讯作者:
    Schwartz SJ
Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro.
当人血浆在体外培养时,类胡萝卜素和α-生育酚在脂蛋白中的分布不会改变。
  • DOI:
    10.1093/jn/125.10.2610
  • 发表时间:
    1995
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Romanchik,JE;Morel,DW;Harrison,EH
  • 通讯作者:
    Harrison,EH
Synthesis of apo-13- and apo-15-lycopenoids, cleavage products of lycopene that are retinoic acid antagonists.
合成apo-13-和apo-15-番茄红素,番茄红素的裂解产物,是视黄酸拮抗剂。
  • DOI:
    10.1194/jlr.d073148
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    6.5
  • 作者:
    Narayanasamy,Sureshbabu;Sun,Jian;Pavlovicz,RyanE;Eroglu,Abdulkerim;Rush,CassandraE;Sunkel,BenjaminD;Li,Chenglong;Harrison,EarlH;CurleyJr,RobertW
  • 通讯作者:
    CurleyJr,RobertW
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EARL Howard HARRISON其他文献

EARL Howard HARRISON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EARL Howard HARRISON', 18)}}的其他基金

FASEB SRC on RETINOIDS
FASEB SRC 关于类维生素A
  • 批准号:
    8318363
  • 财政年份:
    2012
  • 资助金额:
    $ 35.93万
  • 项目类别:
DIETARY CAROTENOIDS--TRANSPORT IN HUMAN PLASMA
膳食类胡萝卜素——在人体血浆中的运输
  • 批准号:
    2225914
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
DIETARY CAROTENOIDS--TRANSPORT IN HUMAN PLASMA
膳食类胡萝卜素——在人体血浆中的运输
  • 批准号:
    2225916
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
DIETARY CAROTENOIDS - LIPOPROTEIN/CELL INTERACTIONS
膳食类胡萝卜素 - 脂蛋白/细胞相互作用
  • 批准号:
    6621641
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
DIETARY CAROTENOIDS - LIPOPROTEIN/CELL INTERACTIONS
膳食类胡萝卜素 - 脂蛋白/细胞相互作用
  • 批准号:
    6692153
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
DIETARY CAROTENOIDS - LIPOPROTEIN/CELL INTERACTIONS
膳食类胡萝卜素 - 脂蛋白/细胞相互作用
  • 批准号:
    6435490
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
DIETARY CAROTENOIDS--LIPOPROTEIN CELL INTERACTIONS
膳食类胡萝卜素--脂蛋白细胞相互作用
  • 批准号:
    2605540
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
DIETARY CAROTENOIDS--LIPOPROTEIN CELL INTERACTIONS
膳食类胡萝卜素--脂蛋白细胞相互作用
  • 批准号:
    6043797
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function
膳食类胡萝卜素的裂解产物:发生情况
  • 批准号:
    8208203
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:
Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function
膳食类胡萝卜素的裂解产物:发生情况
  • 批准号:
    8018594
  • 财政年份:
    1994
  • 资助金额:
    $ 35.93万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了